← Back to headlines
This is What Merck & Co. (MRK) is Doing to Mitigate Against KEYTRUDA Exclusivity Loss
Merck & Co. (MRK) is implementing measures to mitigate the impact of the upcoming loss of exclusivity for its drug KEYTRUDA.
15 Mar, 21:56 — 15 Mar, 21:56
Sources
Showing 1 of 1 sources
